The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2014Neuroimaging Carriers of the Alpha-synuclein E46K Mutation as a Model of Idiopathic Lewy Body Disease
Study Rationale:
In 2004 our group described, for the first time in literature, the E46K mutation of the alpha-synuclein gene in a family from the Basque region of Spain. The rare E46K mutation is... -
Alpha-synuclein Pathology, 2014Development of Diagnostic Biomarker Tests for Parkinson’s Disease
Study Rationale:
An early diagnostic test to identify those with Parkinson’s disease (PD) and to intervene with therapies as early as possible is a critical unmet need. Recent studies have... -
Research Grant, 2014Development and Validation of Biomarker Assays for Improved Diagnosis of Parkinson’s Disease: The Second Generation of Synuclein Assays
Study Rationale:
Lewy bodies composed primarily of the protein alpha-synuclein are important hallmarks of Parkinson’s disease (PD). Available data on the clinical use of alpha... -
Research Grant, 2014Genetic Predictors of Prognosis: GBA and SNCA Meta-Analysis Project
Study Rationale:
Predicting the prognosis of Parkinson’s disease (PD) for a patient is currently not possible. Genetic predictors of prognosis would help inform clinical trial design... -
Access to Data and Biospecimens, 2014Analysis of Brain and Peripheral Small Molecule Levels in Parkinson’s Disease
Study Rationale:
Parkinson’s disease is accompanied by a loss of chemical signaling molecules in the brain and body. For instance, chemicals like dopamine are lost in both the gut and in the brain... -
Access to Data and Biospecimens, 2015Lysosomal Enzyme Activity and GBA1 Genotyping in Parkinson’s Disease
Study Rationale:
The dysfunction of the systems responsible for the clearance of the protein alpha-synuclein plays a major role in Parkinson’s disease (PD). The lysosome is an...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.